Compare · AXGN vs NTUS
AXGN vs NTUS
Side-by-side comparison of Axogen Inc. (AXGN) and Natus Medical Incorporated (NTUS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AXGN and NTUS operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- AXGN is the larger of the two at $2.19B, about 2.9x NTUS ($761.9M).
- AXGN has hit the wire 2 times in the past 4 weeks while NTUS has been quiet.
- AXGN has more recent analyst coverage (8 ratings vs 0 for NTUS).
- Company
- Axogen Inc.
- Natus Medical Incorporated
- Price
- $41.10+4.08%
- $32.97+0.12%
- Market cap
- $2.19B
- $761.9M
- 1M return
- -7.61%
- -
- 1Y return
- +216.15%
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 2
- 0
- Recent ratings
- 8
- 0
Axogen Inc.
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Natus Medical Incorporated
Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was founded in 1987 and is headquartered in Pleasanton, California.
Latest AXGN
- Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
- Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026
- SEC Form 4 filed by Director Burke William P. Mr.
- SEC Form 4 filed by Director Tyndall Joseph A.
- SEC Form 4 filed by Director Levine Alan M
- SEC Form 4 filed by Director Johnson John
- SEC Form 4 filed by Director Thomas Paul
- SEC Form 4 filed by Director Wendell Amy Mcbride
- SEC Form 4 filed by Director Weiler Kathy Johnson
- Axogen Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Latest NTUS
- Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
- SEC Form 15-12G filed by Natus Medical Incorporated
- SEC Form EFFECT filed by Natus Medical Incorporated
- SEC Form EFFECT filed by Natus Medical Incorporated
- SEC Form EFFECT filed by Natus Medical Incorporated
- Novanta Shares Pop On Inclusion Into S&P MidCap 400
- Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600
- SEC Form 4: Schroeder Alice D. returned $750,601 worth of shares to the company (22,406 units at $33.50), closing all direct ownership in the company (for withholding tax)
- SEC Form 4: Moore Bryant M returned $338,819 worth of shares to the company (10,114 units at $33.50), closing all direct ownership in the company (withholding obligation)
- SEC Form 4: Levine Joshua returned $1,252,464 worth of shares to the company (37,387 units at $33.50), closing all direct ownership in the company to cover taxes